6-Hydrazinopyridazine-3-carboxamide

CAS: 3614-47-9

Ref. 3D-DAA61447

Produktinformation

• Name: 6-Hydrazinopyridazine-3-carboxamide
• Synonyme: 3-Hydrazino-6-carbamoylpyridazine, 3-Pyridazinecarboxamide, 6-hydrazino-, 3-Pyridazinecarboxamide, 6-hydrazinyl-, 6-Hydrazino-3-pyridazinecarboxamide, 6-Hydrazinyl-3-pyridazinecarboxamide, 6-Hydrazinylpyridazine-3-Carboxamide, Hidracarbazina, Hidracarbazina [INN-Spanish], Hydracarbazin, Hydracarbazine [INN:DCF], Hydracarbazinum, Hydracarbazinum [INN-Latin], Hydracarbizine, Th 1325, Th 2151, Unii-6Ctk2Fb9Qm

Beschreibung

6-Hydrazinopyridazine-3-carboxamide (HPC) is a drug that regulates the activity of protein genes. It is an antihypertensive agent and has been shown to inhibit the conversion of citrate to ATP in heart tissue, which may be due to its ability to bind to collagen. HPC has biological properties that include inhibition of cardiac contractility and vasodilation, as well as growth factor activity. This drug also inhibits cancer cell proliferation by interfering with the production of growth factors, such as PDGF and FGF. HPC is a coordination complex with dopamine and may have therapeutic effects on Parkinson's disease.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 153.14 g/mol
• Formel: C₅H₇N₅O
• Reinheit: Min. 95%